Indian J Pharm Close
 

Figure 1: (a) Squamous cell carcinoma, (b) urachal mucinous adenocarcinoma, (c) secondary colonic adenocarcinoma, (d) secondary prostatic adenocarcinoma (inset: Prostate-specific antigen positive), (e) leiomyosarcoma (inset: Vimentin positive and Pan-cytokeratin negative), (f) myxoid leiomyosarcoma (Inset: Smooth muscle actin positive)

Figure 1: (a) Squamous cell carcinoma, (b) urachal mucinous adenocarcinoma, (c) secondary colonic adenocarcinoma, (d) secondary prostatic adenocarcinoma (inset: Prostate-specific antigen positive), (e) leiomyosarcoma (inset: Vimentin positive and Pan-cytokeratin negative), (f) myxoid leiomyosarcoma (Inset: Smooth muscle actin positive)